HNPMI
HNPMI is an EGFR inhibitor that induces G0/G1 phase arrest of CRC cells in colorectal cancer, regulates enzymes associated with apoptosis, and can promote apoptosis, and can be used for the study of colorectal cancer.
Product Specifications
CAS Number
1980848-48-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
360.41
Molecular Formula
C22H20N2O3
Notes
Research use only, not for human use.
Receptor
Apoptosis | EGFR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NLB08881-01 50 mg
(1S) -1- (2-Chlorophenyl) -2- (2H-1,2,3,4-tetrazol-2-yl) ethyl carbamate
Sign In for Pricing
View Details NLB08881-02 100 mg
(1S) -1- (2-Chlorophenyl) -2- (2H-1,2,3,4-tetrazol-2-yl) ethyl carbamate
Sign In for Pricing
View Details NLB08881-03 250 mg
(1S) -1- (2-Chlorophenyl) -2- (2H-1,2,3,4-tetrazol-2-yl) ethyl carbamate
Sign In for Pricing
View Details NLB08881-04 500 mg
(1S) -1- (2-Chlorophenyl) -2- (2H-1,2,3,4-tetrazol-2-yl) ethyl carbamate
Sign In for Pricing
View Details